Darifenacin
In Stock•Starting at $57 for 1 mg•Purity ≥ 97%
| CAS No. | 133099-04-4 |
|---|---|
| MDL No. | N/A |
| MF | C28H30N2O2 |
| MW | 426.50 |
| InChI Key | HXGBXQDTNZMWGS-RUZDIDTESA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 1 mg | 99.78% ; | $57 | In Stock | |
| 5 mg | 99.78% ; | $129 | In Stock | |
| 10 mg | ≥97% | $185 | In Stock | |
| 25 mg | 99.78% ; | $383 | In Stock | |
| 50 mg | 99.78% ; | $544 | In Stock |
Product Information
Darifenacin is 2-[(3S)-1-ethylpyrrolidin-3-yl]-2,2-diphenylacetamide with one hydrogen at the 2-position of the ethyl group replaced by a 2,3-dihydro-1-benzofuran-5-yl group. It is a selective M3 muscarinic acetylcholine receptor antagonist, primarily responsible for bladder muscle contractions, and is used as the hydrobromide salt in the treatment of urinary incontinence. It functions as a muscarinic antagonist and antispasmodic drug, and belongs to the classes of 1-benzofurans, pyrrolidines, and monocarboxylic acid amides.
| CAS No. | 133099-04-4 |
|---|---|
| Product Name | Darifenacin |
Biological Targets
CHRM2·CHRM3
Associated Conditions
Urinary incontinence·amyotrophic lateral sclerosis·Polyuria·overactive bladder·urgency urinary incontinence
* The information provided here is compiled from public sources and is for reference only.
